Clinical Trials Browser

Metastatic Castration-resistant Prostate Cancer (mCRPC) × Abiraterone Acetate × Genitourinary × Clear all

NCT03903835 2025-04-09

ProBio

Phase 3 Recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT04862091 2022-03-04

Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer

Phase 2 Completed

Metastatic Castration-resistant Prostate Cancer (mCRPC)